Anti-GARP:TGF-β1 mAbs could thus exert anti-tumor activities via multiple modes of action, by directly or indirectly targeting different cell types depending on the tumor microenvironment (2, 8, 13). The gene discussed is TGFB1; the disease is neoplasm.